about
Aged garlic extract improves endothelial function in men with coronary artery diseaseGenome-wide association study identifies a sequence variant within the DAB2IP gene conferring susceptibility to abdominal aortic aneurysmIntegrated microRNA and messenger RNA analysis in aortic stenosis.Identical pattern of cerebral hypoperfusion during different types of syncope.Syncope is unrelated to supine and postural hypotension following prolonged exercise.Rapid onset of cardiomyopathy in STZ-induced female diabetic mice involves the downregulation of pro-survival Pim-1Plasma heat shock protein 27 is associated with coronary artery disease, abdominal aortic aneurysm and peripheral artery disease.Lipoprotein (a) upregulates ABCA1 in liver cells via scavenger receptor-B1 through its oxidized phospholipidsCirculating microRNA Profiling Needs Further Refinement Before Clinical Use in Patients With Aortic Stenosis.Clinical outcome of older patients with acute coronary syndrome over the last three decades.Cerebral blood flow and cerebrovascular reactivity at rest and during sub-maximal exercise: effect of age and 12-week exercise training.Impaired relaxation despite upregulated calcium-handling protein atrial myocardium from type 2 diabetic patients with preserved ejection fraction.The prevalence, incidence, progression, and risks of aortic valve sclerosis: a systematic review and meta-analysis.Down-regulation of miR-15a/b accelerates fibrotic remodelling in the Type 2 diabetic human and mouse heart.Comparison of three targeted approaches to screening for abdominal aortic aneurysm based on cardiovascular risk.Diagnosis, Incidence, and Clinical Implications of Perioperative Myocardial Injury in Vascular Surgery.Estimating exercise capacity from walking tests in elderly individuals with stable coronary artery disease.Absolute quantification of apolipoproteins and associated proteins on human plasma lipoproteins.Ventricular rate and beat-to-beat variation of stroke volume in atrial fibrillation.Intra-individual changes of active matrix metalloproteinase-9 are associated with clinical in-stent restenosis of bare metal stents.Nonbacterial thrombotic endocarditis with ST-elevation myocardial infarction treated with percutaneous coronary aspiration thrombectomy.Postprandial cytokine concentrations and meal composition in obese and lean women.Novel rare mutations and promoter haplotypes in ABCA1 contribute to low-HDL-C levels.Diabetes induces the activation of pro-ageing miR-34a in the heart, but has differential effects on cardiomyocytes and cardiac progenitor cells.Examining motivations and barriers for attending maintenance community-based cardiac rehabilitation using the health-belief model.Childhood body mass index and endothelial dysfunction evaluated by peripheral arterial tonometry in early midlife.Long-term effects of cardiac rehabilitation in elderly individuals with stable coronary artery disease.Early morning impairment in cerebral autoregulation and cerebrovascular CO2 reactivity in healthy humans: relation to endothelial function.Letter by Coffey et al Regarding Article, "Temporal Trends in the Incidence and Prognosis of Aortic Stenosis: A Nationwide Study of the Swedish Population".Down-regulation of proangiogenic microRNA-126 and microRNA-132 are early modulators of diabetic cardiac microangiopathy.Position statement for the operator and institutional requirements for a transcatheter aortic valve implantation (TAVI) program.Recycling of Apolipoprotein(a) After PlgRKT-Mediated Endocytosis of Lipoprotein(a).The diagnostic sensitivity of circulating cardio-enriched microRNAs is increased after normalization of high-density lipoprotein levels.Elevated plasma active matrix metalloproteinase-9 level is associated with coronary artery in-stent restenosis.Lack of progress in valvular heart disease in the pre-transcatheter aortic valve replacement era: increasing deaths and minimal change in mortality rate over the past three decades.'Exercise snacks' before meals: a novel strategy to improve glycaemic control in individuals with insulin resistance.Repeated Episodes of Remote Ischemic Preconditioning for the Prevention of Myocardial Injury in Vascular Surgery.Coronary artery flow ten weeks after myocardial infarction or unstable angina: effects of combined warfarin and aspirin therapy.Progression of the culprit lesion in unstable coronary artery disease with warfarin and aspirin versus aspirin alone: preliminary study.Plasma active matrix metalloproteinase 9 associated to diastolic dysfunction in patients with coronary artery disease
P50
Q28185079-F9F699FF-0438-4314-A396-1E31A609D07EQ28943557-750FE2A2-4E22-4E1F-BB08-DC3C6A033016Q30829479-C53FD79C-0813-49D5-8F4F-09940D492EE3Q33158187-A0E8B137-7678-4404-9A22-B4793D0BD23DQ33159256-BE418F91-C5FB-4358-B57A-1B3EFC7167E9Q33816171-A23F24A4-E1C5-404A-A8D2-EE3E1F5F2C74Q34446395-0358FEBF-9123-4DA6-878E-41C4A0EE94A6Q35776641-3A38D609-DAEE-485E-9315-B0C13EF10487Q36141660-F72E243C-45F9-40FE-821A-CA719C71305BQ36459937-95922495-0B4D-4709-BC9D-EF97DA904F7EQ36795234-425A23D3-57B1-43E7-ADF9-3BA4C79234A3Q37719325-EF31EA01-74E4-4AFF-8509-D39930BC1B53Q38210701-DBDFF115-4FC4-48FD-90AE-532BFD4A6C4EQ38712391-B33A99A8-F9EE-4F6A-9668-C9FC1BB3B400Q40647177-96DAE18B-36CC-407F-8AB6-159D0EF2355EQ40786991-1B038A6D-A8D3-4413-88CC-657B602E94DCQ43474251-5F8BA8B8-3603-4A88-B36E-7BB2856AC9C6Q43526550-CD945296-3BDC-4A0F-8C77-42F17910F379Q43604522-F182D33A-7284-4083-9233-3F2331F70A95Q45327242-574F02F6-1434-40E1-8F5F-E8757106F79FQ46012773-0D118221-3C8A-44A2-95FB-27EBD6BA4951Q46136920-B85CDDBC-39FB-49CF-A97A-8FAB2ED4183FQ46805420-8381C7CF-6314-40C1-AD50-409600EC02C4Q47231130-708D12AB-E1AC-4307-A562-9B1E5C72CAAEQ47654833-6E18FD01-0350-4974-85DB-445FA81354B8Q47887650-E160347D-7B25-4718-8240-78E1EE08C361Q48025363-16428FC3-2BC5-4351-B3C3-26297F33C6B4Q48229015-7911BAB5-A4C1-4075-98A3-EDCEF4675F44Q50279317-76085D6C-3D71-47B7-A7E6-268E62C48520Q50320378-47B5F86E-1026-4F27-813E-81002ACBFE84Q50443606-E66FB3D2-FF9D-4C2D-A492-F24FC0F2E86FQ50996536-598DCCD8-8470-4DBE-B74A-A3029F08E7E7Q51149059-90AEF79A-BC7D-428D-B808-335A70DC528EQ51204004-9F8B9F98-4283-45D2-A426-8D54950499D4Q51242343-97C75BC0-C851-4FDB-A07C-15AC2FD343E0Q51736004-10BAF6B6-ADA6-4F33-B81C-1B221FD4A33DQ53122668-8C08C01C-25C1-4803-BB2E-6A8149F482F3Q53345497-F4052D1A-D34E-430D-9DFF-46571F9A29D4Q53358418-7F516D9B-DC09-43E5-BD1A-7DC6EB9CEEBAQ57445664-88C52083-F039-4848-9106-FBE0AD84AF51
P50
description
investigador
@es
onderzoeker
@nl
researcher
@en
name
Michael Williams
@ast
Michael Williams
@en
Michael Williams
@es
Michael Williams
@nl
type
label
Michael Williams
@ast
Michael Williams
@en
Michael Williams
@es
Michael Williams
@nl
altLabel
Michael J A Williams
@en
prefLabel
Michael Williams
@ast
Michael Williams
@en
Michael Williams
@es
Michael Williams
@nl
P1053
C-1759-2008
P106
P1153
56091289400
P31
P496
0000-0003-4822-4962